We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.63B
AUM Growth
+$132M
Cap. Flow
+$5.32M
Cap. Flow %
0.33%
Top 10 Hldgs %
35.83%
Holding
242
New
13
Increased
68
Reduced
122
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.4M
2
TMUS icon
T-Mobile US
TMUS
+$4.18M
3
STKL
SunOpta
STKL
+$3.19M
4
UL icon
Unilever
UL
+$2.34M
5
OTLY
Oatly Group
OTLY
+$2.08M

Sector Composition

Rank Sector Weight
1 Healthcare 25.91%
2 Technology 19.96%
3 Industrials 13.27%
4 Communication Services 11.51%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
76
Norfolk Southern
NSC
$75B
$2.2M 0.13%
8,287
+400
+5% +$110K
DE icon
77
Deere & Co
DE
$167B
$2.19M 0.13%
6,215
+99
+2% +$36.1K
ISRG icon
78
Intuitive Surgical
ISRG
$141B
$2.14M 0.13%
6,972
-1,818
-21% -$510K
VUG icon
79
Vanguard Morningstar Growth ETF
VUG
$229B
$2.14M 0.13%
44,712
+300
+0.7% +$13.6K
OTLY
80
Oatly Group
OTLY
$416M
$2.04M 0.13%
+4,177
New +$2.08M
CLX icon
81
Clorox
CLX
$12.8B
$2.03M 0.12%
11,279
-2,495
-18% -$455K
FIS icon
82
Fidelity National Information Services
FIS
$21.4B
$1.99M 0.12%
14,008
-2
-0% -$297
AMGN icon
83
Amgen
AMGN
$224B
$1.88M 0.12%
7,724
-305
-4% -$75K
CSX icon
84
CSX Corp
CSX
$92.6B
$1.84M 0.11%
57,476
-10
-0% -$330
BMY icon
85
Bristol-Myers Squibb
BMY
$130B
$1.8M 0.11%
26,882
-1,730
-6% -$113K
TYL icon
86
Tyler Technologies
TYL
$12.9B
$1.79M 0.11%
3,958
-125
-3% -$53.1K
VIG icon
87
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.77M 0.11%
11,434
-50
-0.4% -$7.67K
INTC icon
88
Intel
INTC
$513B
$1.73M 0.11%
30,869
-4,841
-14% -$284K
ZTS icon
89
Zoetis
ZTS
$30B
$1.66M 0.1%
8,923
-3,114
-26% -$541K
IJH icon
90
iShares Core S&P Mid-Cap ETF
IJH
$127B
$1.58M 0.1%
29,400
+355
+1% +$19.2K
VTI icon
91
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$1.52M 0.09%
6,835
PFE icon
92
Pfizer
PFE
$150B
$1.52M 0.09%
38,717
-20,843
-35% -$811K
TGT icon
93
Target
TGT
$69.2B
$1.5M 0.09%
6,207
-216
-3% -$47.3K
SHW icon
94
Sherwin-Williams
SHW
$87.7B
$1.48M 0.09%
5,432
-391
-7% -$107K
JPM icon
95
JPMorgan Chase
JPM
$970B
$1.44M 0.09%
9,236
+2,135
+30% +$335K
EMR icon
96
Emerson Electric
EMR
$92B
$1.39M 0.09%
14,416
-3
-0% -$282
TXN icon
97
Texas Instruments
TXN
$258B
$1.35M 0.08%
7,045
-40
-0.6% -$7.5K
TSM icon
98
TSMC
TSM
$2.23T
$1.31M 0.08%
10,919
-200
-2% -$23.4K
ECL icon
99
Ecolab
ECL
$78.6B
$1.24M 0.08%
6,007
-290
-5% -$63K
ADBE icon
100
Adobe
ADBE
$102B
$1.16M 0.07%
1,986
-89
-4% -$45.9K

Similar funds

Reynders McVeigh Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Reynders McVeigh Capital Management held 242 positions worth $1.63B, up 8.8% from $1.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q2 2021 filing shows 13 new, 68 increased, 122 reduced and 10 closed positions. Its largest new stake was Oatly Group: 4,177 shares worth $2.04M. The largest sale was Teladoc Health, an estimated $4.11M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q2 2021 buy was Oatly Group: 4,177 shares worth $2.04M.
  • Reynders McVeigh Capital Management added most to Medtronic in Q2 2021, an estimated $5.4M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2021 reduction was Teladoc Health, cutting an estimated $4.11M.
  • Reynders McVeigh Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.65M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.63B portfolio in Q2 2021.
  • Reynders McVeigh Capital Management opened 13 new positions and closed 10 in Q2 2021.
  • Reynders McVeigh Capital Management's portfolio value rose 8.8% quarter-over-quarter to $1.63B.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.